Azienda Ospedaliero Universitaria Policlinico Modena
13
7
8
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Diagnostic Accuracy of a Deep Learning-Based Software for Automated Multiparametric Echocardiographic Measurements
Role: collaborator
Chronology and Sequence of Premonitory Symptoms
Role: collaborator
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Role: collaborator
Effectiveness and Tolerability of Eptinezumab
Role: collaborator
Gepant treAtments: EffectIveNess and tolERability (GAINER)
Role: collaborator
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Role: collaborator
Ditan Acute tReatments: Effectiveness and Tolerability (DART)
Role: collaborator
Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism
Role: collaborator
Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC
Role: lead
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study
Role: collaborator
Use of miRNAs in Growth Hormone Deficiency (GHD)
Role: collaborator
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
Role: collaborator
Non Elective Vulnerable Elderly Radiotherapy
Role: lead
All 13 trials loaded